Research is finding Ketamine Infusion Therapy to be favored over conventional treatment in many cases, and there is a positive developing view as ketamine infusions are becoming a mainstream procedure to address these conditions.
Insurance has been limited by the fact that Ketamine Infusion therapy for treating depression and pain is currently considered off-label.
As a result this has hindered the opportunity for large trials needed for FDA approval, limiting the coverage from insurance companies. However, you should know that insurance coverage can vary greatly and some insurance companies are now considering this treatment as a covered expense.
It is a good idea to contact your insurance company prior to treatment in order to discuss the necessary arrangements for being reimbursed for your expenses.
At this time, many insurance companies may not cover the treatment. However, recently several patients have had success with partial reimbursement with self-filing of claims.
As healthcare professionals, it is our life mission to help people and it is our goal to work with every patient to provide them with the best possible outcomes.
The staff at NeuroMend will make every effort in providing you the proper paperwork and documentation to file with your insurance company to be reimbursed or partially reimbursed for your therapy. Though we cannot determine nor guarantee whether your individual insurance provider will reimburse you, we will work with you personally to guide you throughout the process.
We do not currently submit claims or accept payments from any health insurance provider. Upon request, we will provide an itemized receipt, which may be submitted.
Payment is required either before, or at the time of all services.
NeuroMend Infusion Center accepts payment for your treatments via cash, money order, credit card, or a Health Savings Account.
Whether it's a routine checkup or emergency surgery, you shouldn't have to worry about how to get the best medical care. That’s why we're pleased to accept the CareCredit healthcare credit card.
CareCredit lets you say "yes" to recommend treatment and pay for it in convenient monthly payments that fit your budget.
CareCredit is the healthcare credit card designed exclusively for healthcare services with special financing options.*
With CareCredit, you can use your card for all of your follow-up care as well as annual checkups.
*Subject to credit approval. Minimum monthly payments required. Ask us for details
The Janssen CarePath SPRAVATO® Savings Program is for eligible commercially insured patients.
You can pay $10 per treatment for SPRAVATO® medication costs.
Depending on your health insurance plan, savings may apply toward co-pay, co-insurance, or deductible.
Program does not cover costs to give you your treatment.
Patients can receive up to $8,150 maximum program benefit per calendar year. Treatment may include up to three devices administered on the same day.
Depending on how your insurance covers SPRAVATO®, there is a program benefit limit of list price of the medication and a quantity limit of three devices per day or 23 devices in a 24-day period.
There is a quantity limit of 24 devices in a 24-day period for one use per lifetime.
Terms expire at the end of each calendar year and may change. See program requirements.
You must be enrolled in the Savings Program before receiving your Janssen medication in order to qualify for out-of-pocket cost savings.
Once enrolled, you can share your Savings Program card with your doctor or pharmacist to receive savings on your SPRAVATO® medication costs.
Enroll in the Savings Program by
How your card can be used depends on the insurance you use to pay for your medication:
If you use your medical/primary insurance to pay for your medication through your doctor, treatment provider, or pharmacy:
If you use your pharmacy/prescription insurance to pay for your medication from a pharmacy:
For those involved in patient care, it is important to be aware of the nature and prevalence of suicidal behaviors and the factors that are associated with suicide.